References
- Baldwin, A. S. Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-683 https://doi.org/10.1146/annurev.immunol.14.1.649
- Bowe, W. P., J. C. Filip, J. M. DiRienzo, A. Volgina, and D. J. Margolis. 2006. Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J. Drugs Dermatol. 5: 868-870
- Chen, Q., T. Koga, H. Uchi, H. Hara, H. Terao, Y. Moroi, K. Urabe, and M. Furue. 2002. Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J. Dermatol. Sci. 29: 97-103 https://doi.org/10.1016/S0923-1811(02)00013-0
- Downing, D. T., M. E. Stewart, P. W. Wertz, and J. S. Strauss. 1986. Essential fatty acids and acne. J. Am. Acad. Dermatol. 14: 221-225 https://doi.org/10.1016/S0190-9622(86)70025-X
- Eady, E. A. 1998. Bacterial resistance in acne. Dermatology 196: 59-66 https://doi.org/10.1159/000017869
- Eady, E. A., J. H. Cove, K. T. Holland, and W. J. Cunliffe. 1989. Erythromycin resistant propionibacteria in antibiotic treated acne patients: Association with therapeutic failure. Br. J. Dermatol. 121: 51-57
- Eady, E. A., C. E. Jones, K. J. Gardner, J. P. Taylor, J. H. Cove, and W. J. Cunliffe. 1993. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br. J. Dermatol. 128: 556-560 https://doi.org/10.1111/j.1365-2133.1993.tb00235.x
- Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260 https://doi.org/10.1146/annurev.immunol.16.1.225
- Han, K. S., Y. H. Kim, S. H. Kim, and S. J. Oh. 2007. Characterization and purification of acidocin 1B, a bacteriocin produced by Lactobaciillus acidophilus GP1B. J. Microbiol. Biotechnol. 17: 774-783
- Heymann, W. R. 2006. Toll-like receptors in acne vulgaris. J. Am. Acad. Dermatol. 55: 691-692 https://doi.org/10.1016/j.jaad.2006.05.049
- ack, R. W., J. R. Tagg, and B. Ray. 1995. Bacteriocins of Gram-positive bacteria. Microbiol. Rev. 59: 171-200
- Jappe, U. 2003. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm. Venereol. 83: 241-248 https://doi.org/10.1080/00015550310016463
- Jugeau, S., I. Tenaud, A. C. Knol, V. Jarrousse, G. Quereux, A. Khammari, and B. Dreno. 2005. Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol. 153: 1105-1113 https://doi.org/10.1111/j.1365-2133.2005.06933.x
- Karin, M. and M. Delhase. 2000. The I kappa B kinase (IKK) and NF-kappa B: Key elements of proinflammatory signalling. Semin. Immunol. 12: 85-98 https://doi.org/10.1006/smim.2000.0210
- Kim, J., M. T. Ochoa, S. R. Krutzik, O. Takeuchi, S. Uematsu, A. J. Legaspi, et al. 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169: 1535-1541 https://doi.org/10.4049/jimmunol.169.3.1535
- Lee, K. H., J. Y. Park, S. J. Jeong, G. H. Kwon, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, and J. H. Kim. 2007. Characterization of paraplantaricin C7, a novel bacteriocin produced by Lactobacillus paraplantarum C7 isolate from kimchi. J. Microbiol. Biotechnol. 17: 287-296
- Marta Guarna, M., R. Coulson, and E. Rubinchik. 2006. Antiinflammatory activity of cationic peptides: Application to the treatment of acne vulgaris. FEMS Microbiol. Lett. 257: 1-6 https://doi.org/10.1111/j.1574-6968.2006.00156.x
- McInturff, J. E., S. J. Wang, T. Machleidt, T. R. Lin, A. Oren, C. J. Hertz, et al. 2005. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J. Invest. Dermatol. 125: 256-263 https://doi.org/10.1111/j.0022-202X.2005.23805.x
- Nagaoka, I., S. Yomogida, H. Tamura, and M. Hirata. 2004. Antibacterial cathelicidin peptide CAP11 inhibits the lipopolysaccharide (LPS)-induced suppression of neutrophil apoptosis by blocking the binding of LPS to target cells. Inflamm. Res. 53: 609-622 https://doi.org/10.1007/s00011-004-1300-2
- Nagy, I., A. Pivarcsi, A. Koreck, M. Szell, E. Urban, and L. Kemeny. 2005. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J. Invest. Dermatol. 124: 931-938 https://doi.org/10.1111/j.0022-202X.2005.23705.x
- Nam, C., S. Kim, Y. Sim, and I. Chang. 2003. Anti-acne effects of Oriental herb extracts: A novel screening method to select anti-acne agents. Skin Pharmacol. Appl. Skin Physiol. 16: 84-90 https://doi.org/10.1159/000069030
- Oh, S., S. H. Kim, Y. Ko, J. H. Sim, K. S. Kim, S. H. Lee, S. Park, and Y. J. Kim. 2006. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria. Food Chem. Toxicol. 44: 1184-1190 https://doi.org/10.1016/j.fct.2005.08.008
- Sader, H. S., K. A. Fedler, R. P. Rennie, S. Stevens, and R. N. Jones. 2004. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: Spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob. Agents Chemother. 48: 3112-3118 https://doi.org/10.1128/AAC.48.8.3112-3118.2004
- Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891 https://doi.org/10.4049/jimmunol.169.7.3883
- Scott, M. G., M. R. Gold, and R. E. Hancock. 1999. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect. Immun. 67: 6445-6453
- Scott, M. G. and R. E. Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20: 407-431
- Scott, M. G., A. C. Vreugdenhil, W. A. Buurman, R. E. Hancock, and M. R. Gold. 2000. Cutting edge: Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164: 549-553 https://doi.org/10.4049/jimmunol.164.2.549
- Takeda, K. and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9
- Tan, H. H. 2003. Antibacterial therapy for acne: A guide to selection and use of systemic agents. Am. J. Clin. Dermatol. 4: 307-314 https://doi.org/10.2165/00128071-200304050-00002
- Van Reenen, C. A., W. H. Van Zyl, and L. M. Dicks. 2006. Expression of the immunity protein of plantaricin 423, produced by Lactobacillus plantarum 423, and analysis of the plasmid encoding the bacteriocin. Appl. Environ. Microbiol. 72: 7644-7651 https://doi.org/10.1128/AEM.01428-06
- Vowels, B. R., S. Yang, and J. J. Leyden. 1995. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect. Immun. 63: 3158-3165
- Xiao, W. 2004. Advances in NF-kappaB signaling transduction and transcription. Cell. Mol. Immunol. 1: 425-435
- Zachariae, C. O. 1993. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8. Acta Derm. Venereol. Suppl. (Stockh) 181: 1-37
- Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395 https://doi.org/10.1038/415389a